AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US.

Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some items rose 10% to $2.17, as expected. Under Chief Executive Officer Pascal Soriot’s watch, Astra has turned into an oncology powerhouse and is increasingly focused on the US. Pascal discusses his company's strong quarterly performance and the state of the pharmaceutical industry with Tim Stenovec and Carol Massar on Bloomberg Businessweek Daily.

AstraZeneca Plc reported better-than-expected sales and rising profit for the second quarter, spurred by its stable of cancer medicines and growth in the US. Revenue climbed 12% to $14.5 billion, the UK drugmaker said Tuesday, beating estimates. Earnings per share excluding some items rose 10% to $2.17, as expected. Under Chief Executive Officer Pascal Soriot&rsquo;s watch, Astra has turned into an oncology powerhouse and is increasingly focused on the US. Pascal discusses his company's strong quarterly performance and the state of the pharmaceutical industry with Tim Stenovec and Carol Massar on Bloomberg Businessweek Daily.

Listen for reporting from the magazine that helps global leaders stay ahead. 

Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.  You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: http://bit.ly/3vTiACF. 

Listen for reporting from the magazine that helps global leaders stay ahead. Hosts Carol Massar and Tim Stenovec bring you insight on the people, companies and trends shaping today's complex economy.&nbsp; You can watch and listen to Businessweek LIVE on YouTube, weekdays from 2PM to 5PM ET: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.&nbsp;

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories of global technology, politics, economics and more by harnessing the power of Bloomberg Businessweek reporters and editors.

Bloomberg Businessweek

ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6db3e5d8-e02c-4634-9d65-b32901577bac/transcript

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."
Hosted by Carol Massar and Tim Stenovec

Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.

You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.
Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily." Hosted by Carol Massar and Tim Stenovec Hear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio. You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News. Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BW

Bloomberg Businessweek Weekend - March 13th, 2026 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2efd59f7-b600-446b-9ed0-b40c00f2cb08/transcript

The people, companies and trends shaping the global economy.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.

A federal judge rejected as improper Justice Department subpoenas issued to the Federal Reserve Board seeking records relating to its renovations of its headquarters and Chair Jerome Powell’s comments to Congress about the project.

US District Judge James Boasberg said the government had advanced no evidence to justify the subpoenas and said they clearly reflected an “improper motive” of retaliating against Powell over policy differences. Jeanine Pirro, who leads the US Attorney’s Office for the District of Columbia, called the ruling wrong and said they would appeal the decision.
The White House didn’t immediately respond to a request for comment. The Fed declined to comment.

“A mountain of evidence suggests that the government served these subpoenas on the Board to pressure its Chair into voting for lower interest rates or resigning,” Boasberg said. “On the other side of the scale, the government has produced essentially zero evidence to suspect Chair Powell of a crime; indeed, its justifications are so thin and unsubstantiated that the court can only conclude that they are pretextual.”

DOJ issued subpoenas to the Fed in January threatening a criminal indictment, Powell said at the time. The subpoenas are related to the Fed’s ongoing $2.5 billion renovation of its headquarters in Washington and testimony Powell provided about the construction before the Senate Banking panel last year.

Powell, in an unusually forceful video response to the subpoenas, characterized the investigation as motivated by the Fed refusing to set interest rates according to the preferences of President Donald Trump.

Kevin Warsh, a former Fed governor, has been nominated by Trump to replace Powell when the latter’s term as chair ends in May. North Carolina Republican Thom Tillis, a member of the Senate Banking Committee, has vowed to block any Fed nominations as long as the DOJ investigation of Powell remains unresolved. Tillis reiterated that commitment this week.

Today's show features:
Elliot Stein, Bloomberg Intelligence Senior Litigation Analyst
Mike Collins, PGIM Fixed Income Managing Director & Executive Portfolio Advisor
Oleksandr Komarov, Kyivstar CEO
Katrina Manson, Bloomberg News Reporter covering Tech and National Security

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>. A federal judge rejected as improper Justice Department subpoenas issued to the Federal Reserve Board seeking records relating to its renovations of its headquarters and Chair Jerome Powell&rsquo;s comments to Congress about the project. US District Judge James Boasberg said the government had advanced no evidence to justify the subpoenas and said they clearly reflected an &ldquo;improper motive&rdquo; of retaliating against Powell over policy differences. Jeanine Pirro, who leads the US Attorney&rsquo;s Office for the District of Columbia, called the ruling wrong and said they would appeal the decision. The White House didn&rsquo;t immediately respond to a request for comment. The Fed declined to comment. &ldquo;A mountain of evidence suggests that the government served these subpoenas on the Board to pressure its Chair into voting for lower interest rates or resigning,&rdquo; Boasberg said. &ldquo;On the other side of the scale, the government has produced essentially zero evidence to suspect Chair Powell of a crime; indeed, its justifications are so thin and unsubstantiated that the court can only conclude that they are pretextual.&rdquo; DOJ issued subpoenas to the Fed in January threatening a criminal indictment, Powell said at the time. The subpoenas are related to the Fed&rsquo;s ongoing $2.5 billion renovation of its headquarters in Washington and testimony Powell provided about the construction before the Senate Banking panel last year. Powell, in an unusually forceful video response to the subpoenas, characterized the investigation as motivated by the Fed refusing to set interest rates according to the preferences of President Donald Trump. Kevin Warsh, a former Fed governor, has been nominated by Trump to replace Powell when the latter&rsquo;s term as chair ends in May. North Carolina Republican Thom Tillis, a member of the Senate Banking Committee, has vowed to block any Fed nominations as long as the DOJ investigation of Powell remains unresolved. Tillis reiterated that commitment this week. Today's show features:
<ul>
<li>Elliot Stein, Bloomberg Intelligence Senior Litigation Analyst</li>
<li>Mike Collins, PGIM Fixed Income Managing Director &amp; Executive Portfolio Advisor</li>
<li>Oleksandr Komarov, Kyivstar CEO</li>
<li>Katrina Manson, Bloomberg News Reporter covering Tech and National Security</li>
</ul>

Judge Rejects Subpoenas of Fed Board in Powell Case

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/01618064-f8d7-4647-b5d2-b40c01619f44/transcript

Today the world of private equity and credit is a rancid pool of conflicts and illegality that cannot possibly be seen as superior to public markets. Private equity executives even enjoy special tax provisions from Congress for "carried interest" to reward them for their efforts in soaking investors. Advocates of private schemes like crypto tokens, which are explicitly not considered securities, buy and sell Members of Congress like chattel.

Chris Whalen, former banker and risk analyst weighs in on the latest concerns in private credit on the back of this week’s headlines including JPMorgan Chase restricting some lending to private credit funds after marking down the value of certain software-linked loans in its portfolios. AS well as Morgan Stanley and Cliffwater capping withdrawals from their private credit funds

Today the world of private equity and credit is a rancid pool of conflicts and illegality that cannot possibly be seen as superior to public markets. Private equity executives even enjoy special tax provisions from Congress for "carried interest" to reward them for their efforts in soaking investors. Advocates of private schemes like crypto tokens, which are explicitly not considered securities, buy and sell Members of Congress like chattel. Chris Whalen, former banker and risk analyst weighs in on the latest concerns in private credit on the back of this week&rsquo;s headlines including JPMorgan Chase restricting some lending to private credit funds after marking down the value of certain software-linked loans in its portfolios. AS well as Morgan Stanley and Cliffwater capping withdrawals from their private credit funds

Private Credit’s ‘Back Leverage’ Is Another Pain Point for Funds

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/24d0c83c-dce0-444b-a5b0-b40b015470f6/transcript

ICYMI: AstraZeneca Profit, Revenue Lifted by Cancer Drugs

In 1 playlist(s)

Bloomberg Businessweek

Social links

Follow podcast

Recent clips